Founders of health and biotech unicorns are older on average, Ali Tamaseb said.
The notion of the teenage and twenty-something technology entrepreneur looms large. In reality, the most successful companies are more commonly founded by people in their 30s or older. Among startups valued at $1 billion or more created over the last 15 years, the median age of the founders when starting their businesses was 34, according to research in a new book called Super Founders: What Data Reveals About Billion-Dollar Startups.
The finding offers new evidence that leaders with some experience bring advantages, said Ali Tamaseb, the author and a partner at the venture capital firm DCVC. There are, indeed, many successful billion-dollar startup founders in their early twenties, Tamaseb wrote in the book, but most of them aren t. His takeaway: Age doesn t matter.
The typical unicorn founder started their business at 34
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
COVID-19 Clinical Trails Market Projected to Grow at a CAGR of 10 2% During the Forecast Period 2021-2026
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
How BYU scientists struck pharmaceutical gold â and the fight over who keeps the money
For the past decade, scientists have been fighting over the proceeds from the massive settlement with Pfizer
(Illustration by Christopher Cherrington | The Salt Lake Tribune)
Editorâs note ⢠This story is available to Salt Lake Tribune subscribers only. Thank you for supporting local journalism.
One day in 2012, Weilin Xie got a call out of the blue telling him he had $1 million coming his way.
No, Xie had not won a lottery. His former professor, Brigham Young University biochemist Daniel Simmons, had called to tell him the money was for Xieâs participation 20 years earlier in research that led to the development of blockbuster anti-inflammatory drug Celebrex.